Does Dr. MUSTAFA AHMED have financial conflicts of interest?

Dr. MUSTAFA AHMED (MD) has received a total of $7,608 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $7,608 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MUSTAFA AHMED?

According to CMS Open Payments data, Dr. MUSTAFA AHMED received funding from BOSTON SCIENTIFIC CORPORATION ($2,334), RELIEVANT MEDSYSTEMS ($1,499), and ASTELLAS PHARMA US ($549).

Does Dr. MUSTAFA AHMED receive research grants or speaking fees?

Dr. MUSTAFA AHMED has received $7,608 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MUSTAFA AHMED

MDReal-Time Hydrated

Specialty: Physician Assistant, Medical

Practice Location: SAINT LOUIS, MO 63141

NPI Number: 1548881659

LIFETIME INDUSTRY VALUE

$7,608

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AHMED is a verified Physician Assistant, Medical practitioner based in SAINT LOUIS, MO.

Between 2021 and 2025, Dr. AHMED had an overall industry promotional and research financial footprint of $7,608 as recorded in the federal CMS Open Payments database.

$7,608 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AHMED's primary funding source is BOSTON SCIENTIFIC CORPORATION, which accounts for $2,334 (representing 30.7% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BOSTON SCIENTIFIC CORPORATION

Rank 1

$2,334

30.7%

RELIEVANT MEDSYSTEMS

Rank 2

$1,499

19.7%

ASTELLAS PHARMA US

Rank 3

$549

7.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.